Financial Management Professionals’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
LMFP
PR
AAS
MFS
EWM
LHWM
MWA
PI
SWM
MAM
Financial Management Professionals's XBI Position: Q2 2026 in Review
Financial Management Professionals increased its State Street SPDR S&P Biotech ETF (XBI) stake by 4,186% in Q2 2026, buying an estimated $1.58M and bringing the position to 12,000 shares worth $1.9M. The position accounts for 0.18% of the portfolio, ranked #46.
Financial Management Professionals first reported a position in XBI in Q4 2017 and has held it in 27 quarters since. The position peaked at $3.1M in Q1 2018. 131 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Financial Management Professionals held 12,000 shares of State Street SPDR S&P Biotech ETF worth $1.9M as of Q2 2026.
- Financial Management Professionals bought 11,720 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.58M.
- State Street SPDR S&P Biotech ETF made up 0.18% of Financial Management Professionals's portfolio in Q2 2026, its #46 holding.
- Financial Management Professionals first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 27 quarters since.
- Financial Management Professionals's State Street SPDR S&P Biotech ETF position peaked at $3.1M in Q1 2018.
- 131 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.